Science Current Events | Science News | Brightsurf.com
 

Recent HIV Current Events | HIV News

Page 1 of 25 | 620 Results
Previous0102030405060708091011   Next   
Sort By: Relevance | Page Views
Selenium may slow march of AIDS
Increasing the production of naturally occurring proteins that contain selenium in human blood cells slows down multiplication of the AIDS virus, according to biochemists.   view more (2008-12-01)

ACP recommends routine HIV screening for all patients
On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the Annals of Internal Medicine Web site at www.annals.org.   view more (2008-12-01)

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus... view more (2008-11-24)

Landmark study defines benefits of early HIV testing and treatment for infected infants
Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine.   view more (2008-11-20)

First Holistic Guide to Primate Disease Covers Critical Gap in Global Health
Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them?   view more (2008-11-19)

Study finds Canada's supervised injection facility cost-effective
Canada's only supervised injection facility is extending lives and saving the health-care system millions of dollars, a new study shows.   view more (2008-11-18)

Results of landmark study of HIV vaccine published in the Lancet
Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV... view more (2008-11-13)

Researchers describe how cells take out the trash to prevent disease
Garbage collectors are important for removing trash; without them waste accumulates and can quickly become a health hazard. Similarly, individual cells that make up such biological organisms as humans also have sophisticated methods for managing waste.   view more (2008-11-11)

Researchers use chemical from medicinal plants to fight HIV
Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised.   view more (2008-11-10)

Engineered killer T cell recognizes HIV-1's lethal molecular disguises
Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system.   view more (2008-11-10)

T cell-based HIV vaccine candidate demonstrates positive results
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.   view more (2008-11-10)

Protein identified that turns off HIV-fighting T cells
In HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing... view more (2008-11-10)

DNA chunks, chimps and humans
Researchers have carried out the largest study of differences between human and chimpanzee genomes, identifying regions that have been duplicated or lost during evolution of the two lineages.   view more (2008-11-06)

New HIV-reduction initiative takes to the fields
Education has found its way onto the soccer fields of North Carolina - in the form of a social experiment that may have all the right ingredients to change the direction of Latino health in the United States.   view more (2008-11-06)

XDR-TB: Deadlier and more mysterious than ever
New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials.   view more (2008-11-06)

Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.   view more (2008-11-04)

Study finds fears of HIV transmission in families with infected parent
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.   view more (2008-11-04)

How HIV vaccine might have increased odds of infection
In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection.   view more (2008-11-03)

Rapid HIV testing in the ER boosts diagnoses, screening
One in every 50 people screened for a suspected sexually transmitted infection (STI) in the Emergency Department at Henry Ford Hospital was found to be infected with HIV using a rapid blood sample screening test.   view more (2008-10-27)

UCLA develops safer, more effective TB vaccine for HIV-positive people
UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials.   view more (2008-10-24)

Adult liver transplant eligibility criteria
The pain is debilitating. The only option: smoking medical marijuana. That's the reality for many hepatitis C patients whose road to health includes a liver transplant.   view more (2008-10-23)

Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
Episodic treatment of HIV/AIDS with antiretroviral drugs increases the overall risk of death when compared with continuous antiretroviral treatment (ART), but the reasons why have been unknown.   view more (2008-10-22)

Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune... view more (2008-10-21)

Integrating antiretroviral therapy with TB treatment for co-infections reduces mortality
A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time.   view more (2008-10-17)

Efavirenz-Based Initial Therapies Associated with Better Outcomes in HIV-Infected Adults
A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug efavirenz were more likely to adhere to treatment and less likely to experience virologic failure and death compared to patients taking nevirapine.   view more (2008-10-15)
Page 1 of 25 | 620 Results
Previous0102030405060708091011   Next   
Sort By: Relevance | Page Views
© 2008 BrightSurf.com